ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,013, issued on Sept. 22, was assigned to Horizon Therapeutics Ireland DAC (Dublin).
"IGF1R antibodies" was invented by Christopher Davidson Ward (Kensington, Md.) and Martin Jack Borrok III (North Potomac, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are antibodies that bind and inhibit signaling through the insulin-like growth factor receptor 1."
The patent was filed on June 8, 2023, under Application No. 18/331,535.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=...